| Product Code: ETC13261117 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Health Screening Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Health Screening Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Health Screening Market Revenues & Volume, 2021 & 2031F |
3.3 North America Health Screening Market - Industry Life Cycle |
3.4 North America Health Screening Market - Porter's Five Forces |
3.5 North America Health Screening Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Health Screening Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.7 North America Health Screening Market Revenues & Volume Share, By Package Type, 2021 & 2031F |
3.8 North America Health Screening Market Revenues & Volume Share, By Panel Type, 2021 & 2031F |
3.9 North America Health Screening Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.10 North America Health Screening Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.11 North America Health Screening Market Revenues & Volume Share, By Sample Collection Sites, 2021 & 2031F |
3.12 North America Health Screening Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 North America Health Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Health Screening Market Trends |
6 North America Health Screening Market, 2021 - 2031 |
6.1 North America Health Screening Market, Revenues & Volume, By Test Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Health Screening Market, Revenues & Volume, By Cholesterol Tests, 2021 - 2031 |
6.1.3 North America Health Screening Market, Revenues & Volume, By Diabetes Test, 2021 - 2031 |
6.1.4 North America Health Screening Market, Revenues & Volume, By Cancer Screening, 2021 - 2031 |
6.1.5 North America Health Screening Market, Revenues & Volume, By General Check Up Test, 2021 - 2031 |
6.1.6 North America Health Screening Market, Revenues & Volume, By STDs, 2021 - 2031 |
6.1.7 North America Health Screening Market, Revenues & Volume, By Blood Pressure Test, 2021 - 2031 |
6.1.8 North America Health Screening Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 North America Health Screening Market, Revenues & Volume, By Package Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Health Screening Market, Revenues & Volume, By Basic Health Screening, 2021 - 2031 |
6.2.3 North America Health Screening Market, Revenues & Volume, By Senior Citizen Profile, 2021 - 2031 |
6.2.4 North America Health Screening Market, Revenues & Volume, By Women Health Check, 2021 - 2031 |
6.2.5 North America Health Screening Market, Revenues & Volume, By Men Health Check, 2021 - 2031 |
6.2.6 North America Health Screening Market, Revenues & Volume, By Heart Check, 2021 - 2031 |
6.2.7 North America Health Screening Market, Revenues & Volume, By Diabetes Check, 2021 - 2031 |
6.2.8 North America Health Screening Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 North America Health Screening Market, Revenues & Volume, By Panel Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Health Screening Market, Revenues & Volume, By Multi-Test Panels, 2021 - 2031 |
6.3.3 North America Health Screening Market, Revenues & Volume, By Single-Test Panels, 2021 - 2031 |
6.4 North America Health Screening Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Health Screening Market, Revenues & Volume, By Blood, 2021 - 2031 |
6.4.3 North America Health Screening Market, Revenues & Volume, By Urine, 2021 - 2031 |
6.4.4 North America Health Screening Market, Revenues & Volume, By Serum, 2021 - 2031 |
6.4.5 North America Health Screening Market, Revenues & Volume, By Saliva, 2021 - 2031 |
6.4.6 North America Health Screening Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 North America Health Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Health Screening Market, Revenues & Volume, By Immunoassays, 2021 - 2031 |
6.5.3 North America Health Screening Market, Revenues & Volume, By Medical Imaging, 2021 - 2031 |
6.5.4 North America Health Screening Market, Revenues & Volume, By QPCR (Quantitative Polymerase Chain Reaction), 2021 - 2031 |
6.5.5 North America Health Screening Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 North America Health Screening Market, Revenues & Volume, By Sample Collection Sites, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Health Screening Market, Revenues & Volume, By Hospital, 2021 - 2031 |
6.6.3 North America Health Screening Market, Revenues & Volume, By Homes, 2021 - 2031 |
6.6.4 North America Health Screening Market, Revenues & Volume, By Diagnostic Laboratories, 2021 - 2031 |
6.6.5 North America Health Screening Market, Revenues & Volume, By Offices, 2021 - 2031 |
6.6.6 North America Health Screening Market, Revenues & Volume, By Others, 2021 - 2031 |
6.7 North America Health Screening Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 North America Health Screening Market, Revenues & Volume, By Direct Tenders, 2021 - 2031 |
6.7.3 North America Health Screening Market, Revenues & Volume, By Retail Sales, 2021 - 2031 |
6.7.4 North America Health Screening Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Health Screening Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Health Screening Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.1 United States (US) Health Screening Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.2 Canada Health Screening Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.3 Rest of North America Health Screening Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.3 North America Health Screening Market Revenues & Volume Share, By Package Type, 2021 & 2031F |
7.3.1 United States (US) Health Screening Market, Revenues & Volume, By Package Type, 2021 - 2031 |
7.3.2 Canada Health Screening Market, Revenues & Volume, By Package Type, 2021 - 2031 |
7.3.3 Rest of North America Health Screening Market, Revenues & Volume, By Package Type, 2021 - 2031 |
7.4 North America Health Screening Market, Revenues & Volume, By Panel Type, 2021 - 2031 |
7.4.1 United States (US) Health Screening Market, Revenues & Volume, By Panel Type, 2021 - 2031 |
7.4.2 Canada Health Screening Market, Revenues & Volume, By Panel Type, 2021 - 2031 |
7.4.3 Rest of North America Health Screening Market, Revenues & Volume, By Panel Type, 2021 - 2031 |
7.5 North America Health Screening Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.5.1 United States (US) Health Screening Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.5.2 Canada Health Screening Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.5.3 Rest of North America Health Screening Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.6 North America Health Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.1 United States (US) Health Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.2 Canada Health Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6.3 Rest of North America Health Screening Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.7 North America Health Screening Market, Revenues & Volume, By Sample Collection Sites, 2021 - 2031 |
7.7.1 United States (US) Health Screening Market, Revenues & Volume, By Sample Collection Sites, 2021 - 2031 |
7.7.2 Canada Health Screening Market, Revenues & Volume, By Sample Collection Sites, 2021 - 2031 |
7.7.3 Rest of North America Health Screening Market, Revenues & Volume, By Sample Collection Sites, 2021 - 2031 |
7.8 North America Health Screening Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.8.1 United States (US) Health Screening Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.8.2 Canada Health Screening Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.8.3 Rest of North America Health Screening Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 North America Health Screening Market Key Performance Indicators |
9 North America Health Screening Market - Export/Import By Countries Assessment |
10 North America Health Screening Market - Opportunity Assessment |
10.1 North America Health Screening Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Health Screening Market Opportunity Assessment, By Test Type, 2021 & 2031F |
10.3 North America Health Screening Market Opportunity Assessment, By Package Type, 2021 & 2031F |
10.4 North America Health Screening Market Opportunity Assessment, By Panel Type, 2021 & 2031F |
10.5 North America Health Screening Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
10.6 North America Health Screening Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.7 North America Health Screening Market Opportunity Assessment, By Sample Collection Sites, 2021 & 2031F |
10.8 North America Health Screening Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 North America Health Screening Market - Competitive Landscape |
11.1 North America Health Screening Market Revenue Share, By Companies, 2022 |
11.2 North America Health Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here